Significant Accounting Policies (Details) (USD $)	3 Months Ended	12 Months Ended
	Dec. 31, 2011	Dec. 31, 2013	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010
Loss Attributable to Noncontrolling Interest
Noncontrolling interest, ownership percentage					74.00%
Net loss attributable to non-controlling interest		$ (252,000)	$ (84,000)	$ 0
Concentrations of Credit Risk
Concentration of risk, cash and cash equivalents		45,900,000	14,700,000
Revenue Recognition
Revenues		5,100,000	5,500,000	6,000,000
Reserve for sales returns	3,400,000
Accrual for product returns		2,400,000	1,100,000
Allowance for chargebacks		25,000,000	14,800,000
Fee-for-service accurals and allowances		3,100,000	3,600,000
Advertising Costs
Advertising expense		400,000	200,000	600,000
Minimum [Member]
Share-based Compensation
Historic volatility period		12
Maximum [Member]
Share-based Compensation
Historic volatility period		60
Angiomax [Member]
Revenue Recognition
Deferred revenue		800,000
Cleviprex [Member]
Revenue Recognition
Deferred revenue		3,000,000	1,600,000
Revenues		16,000,000	10,400,000	800,000
Integrated Commercialization Solutions, Inc [Member] | Sales Revenue, Goods, Net [Member] | Customer Concentration Risk [Member]
Concentrations of Credit Risk
Concentration risk, percentage		89.00%	90.00%	96.00%
Integrated Commercialization Solutions, Inc [Member] | Accounts Receivable [Member] | Customer Concentration Risk [Member]
Concentrations of Credit Risk
Concentration risk, percentage		92.00%	89.00%
Accounts receivable, gross		$ 120,900,000	$ 92,300,000